Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide.
about
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryOxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model.Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.Pharmacotherapeutic targets in Alzheimer's diseaseKynurenines, neurodegeneration and Alzheimer's disease.Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats.Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.
P2860
Q24630927-ABCE64DA-0CAB-4F41-8E80-1552D3A07091Q33506441-28543A32-6E5C-476C-BD4D-2B5EB56CF072Q33639885-CC07FE79-3846-400F-BFE3-277EC53D7038Q34461389-F9D44790-5210-48F0-800A-365EA2443BF5Q36076365-597EDF73-2F1C-4EB8-8117-0C24A2B5C514Q36872887-07F0C701-3386-409A-A4F0-2465DB25C038Q37295067-D9C7A91E-03C2-4DF2-AAA7-A74F888933FFQ37772582-FC938499-A30F-403A-A47C-C4AF464B5A1CQ39324761-AB2E5914-3D03-4C90-B60B-24FC503FF970Q40683231-8906DDF8-1C27-4C79-8DFF-FF0214D8200BQ42426545-4D560C05-E24E-48E6-8ABC-BDB72C1E35C1Q42920869-17F0B5AE-9DD3-4C16-8251-4D219A7D6CF4Q45896609-A5F27F0D-27CF-4A06-9F68-C43EE1484B4BQ47372795-A8B87398-DCB0-45AB-8960-ED516FB64B6E
P2860
Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Copper-dependent inhibition of cytochrome c oxidase by Abeta
@nl
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en-gb
type
label
Copper-dependent inhibition of cytochrome c oxidase by Abeta
@nl
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en-gb
prefLabel
Copper-dependent inhibition of cytochrome c oxidase by Abeta
@nl
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en-gb
P2860
P50
P1476
Copper-dependent inhibition of ...... sidue 35 of the Abeta peptide.
@en
P2093
Kevin J Barnham
Rachel E Blake
P2860
P304
P356
10.1111/J.1471-4159.2006.04050.X
P407
P577
2006-10-01T00:00:00Z